HF
EOLS icon

HRT Financial’s Evolus EOLS Stock Holding History

HRT Financial’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-428,647
Closed -$2.85M – 4034
2025
Q4 		$2.85M Buy
+428,647
New +$2.9M 0.01% 1077
2025
Q2 		– Sell
-12,564
Closed -$151K – 2867
2025
Q1 		$151K Sell
12,564
-10,967
-47% -$143K ﹤0.01% 2082
2024
Q4 		$259K Sell
23,531
-13,006
-36% -$183K ﹤0.01% 1795
2024
Q3 		$591K Buy
+36,537
New +$511K ﹤0.01% 1513
2024
Q2 		– Sell
-26,165
Closed -$366K – 2441
2024
Q1 		$366K Buy
26,165
+4,050
+18% +$52.6K ﹤0.01% 1435
2023
Q4 		$232K Buy
22,115
+1,280
+6% +$11.4K ﹤0.01% 1731
2023
Q3 		$190K Buy
+20,835
New +$187K ﹤0.01% 1848
2021
Q4 		– Sell
-118,492
Closed -$902K – 3397
2021
Q3 		$902K Buy
+118,492
New +$1.23M 0.01% 1433

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's EOLS Position: Q1 2026 in Review

HRT Financial sold out of Evolus (EOLS) in Q1 2026, closing a stake of 428,647 shares — an estimated $2.85M sold.

HRT Financial first reported a position in EOLS in Q3 2021 and held it in 8 quarters. The position peaked at $2.85M in Q4 2025. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • HRT Financial reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 428,647 Evolus shares in Q1 2026, an estimated $2.85M.
  • HRT Financial first reported a position in Evolus in Q3 2021 and held it in 8 quarters.
  • HRT Financial's Evolus position peaked at $2.85M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.